SRX Global (SRXH)
Market Price (7/30/2026): $1.42 | Market Cap: $424.7 MilSector: Consumer Staples | Industry: Packaged Foods & Meats
SRX Global (SRXH)
Market Price (7/30/2026): $1.42Market Cap: $424.7 MilSector: Consumer StaplesIndustry: Packaged Foods & Meats
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Megatrend and thematic driversMegatrends include Digital Health & Telemedicine. Themes include Remote Patient Monitoring, Health Data Analytics, and AI in Healthcare Management. | Weak multi-year price returns2Y Excs Rtn is -134%, 3Y Excs Rtn is -160% | Very low revenueRev LTMTotal Revenue or Sales, Last Twelve Months is -17 Mil Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -2.3 Mil Weak revenue growthRev Chg QQuarterly Revenue Change % is -52% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -15% High stock price volatilityVol 12M is 191% Key risksSRXH key risks include [1] severe financial distress with substantial "going concern" doubt from management and its auditor, Show more. |
| Megatrend and thematic driversMegatrends include Digital Health & Telemedicine. Themes include Remote Patient Monitoring, Health Data Analytics, and AI in Healthcare Management. |
| Weak multi-year price returns2Y Excs Rtn is -134%, 3Y Excs Rtn is -160% |
| Very low revenueRev LTMTotal Revenue or Sales, Last Twelve Months is -17 Mil |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -2.3 Mil |
| Weak revenue growthRev Chg QQuarterly Revenue Change % is -52% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -15% |
| High stock price volatilityVol 12M is 191% |
| Key risksSRXH key risks include [1] severe financial distress with substantial "going concern" doubt from management and its auditor, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Updated on 7/27/2026
SRX Global (SRXH) stock has lost about 80% since 3/31/2026 because of the following key factors:
1. Persistent Unprofitability and Negative Market Reaction to Fiscal Q2 2026 Results.
SRX Global reported a significant net loss of $6.4 million for its fiscal second quarter ending March 31, 2026. Despite a 23% quarter-over-quarter revenue growth to $3.4 million and a 44% improvement in adjusted EBITDA loss to $(0.6) million, the market reacted negatively to the fiscal Q2 2026 earnings announcement on May 14, 2026. The stock declined 9.4% the day following the announcement and continued to drift 27.4% lower over the subsequent 41 days, signaling investor skepticism regarding its path to profitability.
2. Significant Share Dilution and Regulatory Compliance Issues Culminating in a Reverse Stock Split.
Shareholders experienced substantial dilution, with total shares outstanding increasing by 2405.1% over the past year. Adding to investor confidence erosion, the company received a public warning letter from the NYSE American in February 2026 concerning the improper issuance of 7.5 million common shares without prior listing approval. Further exacerbating the situation, a 60-to-1 reverse stock split was approved on June 24, 2026, and became effective on July 6, 2026. This measure was undertaken to regain compliance with NYSE American minimum stockholders' equity requirements after the stock closed below $0.10 on June 23, 2026, leading to a nearly 20% plunge in the stock on June 24, 2026.
Show more
SRX Global (SRXH) stock has lost about 80% since 3/31/2026 because of the following key factors:
1. Persistent Unprofitability and Negative Market Reaction to Fiscal Q2 2026 Results.
SRX Global reported a significant net loss of $6.4 million for its fiscal second quarter ending March 31, 2026. Despite a 23% quarter-over-quarter revenue growth to $3.4 million and a 44% improvement in adjusted EBITDA loss to $(0.6) million, the market reacted negatively to the fiscal Q2 2026 earnings announcement on May 14, 2026. The stock declined 9.4% the day following the announcement and continued to drift 27.4% lower over the subsequent 41 days, signaling investor skepticism regarding its path to profitability.
2. Significant Share Dilution and Regulatory Compliance Issues Culminating in a Reverse Stock Split.
Shareholders experienced substantial dilution, with total shares outstanding increasing by 2405.1% over the past year. Adding to investor confidence erosion, the company received a public warning letter from the NYSE American in February 2026 concerning the improper issuance of 7.5 million common shares without prior listing approval. Further exacerbating the situation, a 60-to-1 reverse stock split was approved on June 24, 2026, and became effective on July 6, 2026. This measure was undertaken to regain compliance with NYSE American minimum stockholders' equity requirements after the stock closed below $0.10 on June 23, 2026, leading to a nearly 20% plunge in the stock on June 24, 2026.
Show more
Updated on 7/27/2026
SRX Global (SRXH) stock has lost about 80% since 3/31/2026 because of the following key factors:
1. Persistent Unprofitability and Negative Market Reaction to Fiscal Q2 2026 Results.
SRX Global reported a significant net loss of $6.4 million for its fiscal second quarter ending March 31, 2026. Despite a 23% quarter-over-quarter revenue growth to $3.4 million and a 44% improvement in adjusted EBITDA loss to $(0.6) million, the market reacted negatively to the fiscal Q2 2026 earnings announcement on May 14, 2026. The stock declined 9.4% the day following the announcement and continued to drift 27.4% lower over the subsequent 41 days, signaling investor skepticism regarding its path to profitability.
2. Significant Share Dilution and Regulatory Compliance Issues Culminating in a Reverse Stock Split.
Shareholders experienced substantial dilution, with total shares outstanding increasing by 2405.1% over the past year. Adding to investor confidence erosion, the company received a public warning letter from the NYSE American in February 2026 concerning the improper issuance of 7.5 million common shares without prior listing approval. Further exacerbating the situation, a 60-to-1 reverse stock split was approved on June 24, 2026, and became effective on July 6, 2026. This measure was undertaken to regain compliance with NYSE American minimum stockholders' equity requirements after the stock closed below $0.10 on June 23, 2026, leading to a nearly 20% plunge in the stock on June 24, 2026.
3. Unproven Strategic Pivot to Digital Assets Amidst Market Volatility.
SRX Global underwent a strategic pivot towards AI-enabled analytics and digital asset treasury management, including investments in cryptocurrencies. While the company claimed this active cryptocurrency strategy reduced losses by 23% relative to a buy-and-hold approach, it has not yet translated into proven profitability. This shift occurred during a challenging market environment where Bitcoin and Ethereum collectively declined 27% over a six-month trading period, introducing an additional layer of risk and uncertainty to the company's financial performance. The company completed the acquisition of EMJ Crypto Technologies and rebranded to SRX Global Inc. on June 18, 2026.
4. Severe Financial Distress and "Going Concern" Doubt.
SRX Global faces severe financial distress, accompanied by substantial "going concern" doubt from both management and its auditor. The company's GF Score™ is notably low at 14/100, indicating significant potential challenges in financial performance and growth, which further deterred investor interest.
Show less
SRX Global (SRXH) stock has lost about 80% since 3/31/2026 because of the following key factors:
1. Persistent Unprofitability and Negative Market Reaction to Fiscal Q2 2026 Results.
SRX Global reported a significant net loss of $6.4 million for its fiscal second quarter ending March 31, 2026. Despite a 23% quarter-over-quarter revenue growth to $3.4 million and a 44% improvement in adjusted EBITDA loss to $(0.6) million, the market reacted negatively to the fiscal Q2 2026 earnings announcement on May 14, 2026. The stock declined 9.4% the day following the announcement and continued to drift 27.4% lower over the subsequent 41 days, signaling investor skepticism regarding its path to profitability.
2. Significant Share Dilution and Regulatory Compliance Issues Culminating in a Reverse Stock Split.
Shareholders experienced substantial dilution, with total shares outstanding increasing by 2405.1% over the past year. Adding to investor confidence erosion, the company received a public warning letter from the NYSE American in February 2026 concerning the improper issuance of 7.5 million common shares without prior listing approval. Further exacerbating the situation, a 60-to-1 reverse stock split was approved on June 24, 2026, and became effective on July 6, 2026. This measure was undertaken to regain compliance with NYSE American minimum stockholders' equity requirements after the stock closed below $0.10 on June 23, 2026, leading to a nearly 20% plunge in the stock on June 24, 2026.
3. Unproven Strategic Pivot to Digital Assets Amidst Market Volatility.
SRX Global underwent a strategic pivot towards AI-enabled analytics and digital asset treasury management, including investments in cryptocurrencies. While the company claimed this active cryptocurrency strategy reduced losses by 23% relative to a buy-and-hold approach, it has not yet translated into proven profitability. This shift occurred during a challenging market environment where Bitcoin and Ethereum collectively declined 27% over a six-month trading period, introducing an additional layer of risk and uncertainty to the company's financial performance. The company completed the acquisition of EMJ Crypto Technologies and rebranded to SRX Global Inc. on June 18, 2026.
4. Severe Financial Distress and "Going Concern" Doubt.
SRX Global faces severe financial distress, accompanied by substantial "going concern" doubt from both management and its auditor. The company's GF Score™ is notably low at 14/100, indicating significant potential challenges in financial performance and growth, which further deterred investor interest.
Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →
Stock Movement Drivers
Fundamental Drivers
The -80.8% change in SRXH stock from 3/31/2026 to 7/29/2026 was primarily driven by a -95.2% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 3312026 | 7292026 | Change |
|---|---|---|---|
| Stock Price ($) | 7.56 | 1.45 | -80.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | � | -17 | 0.0% |
| P/S Multiple | � | -25.7 | 0.0% |
| Shares Outstanding (Mil) | 14 | 299 | -95.2% |
| Cumulative Contribution | 0.0% |
Market Drivers
3/31/2026 to 7/29/2026| Return | Correlation | |
|---|---|---|
| SRXH | -80.8% | |
| Market (SPY) | 12.2% | -2.9% |
| Sector (XLP) | 6.6% | -5.0% |
Fundamental Drivers
The -89.2% change in SRXH stock from 12/31/2025 to 7/29/2026 was primarily driven by a -349.9% change in the company's P/S Multiple.| (LTM values as of) | 12312025 | 7292026 | Change |
|---|---|---|---|
| Stock Price ($) | 13.38 | 1.45 | -89.2% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 27 | -17 | -163.6% |
| P/S Multiple | 10.3 | -25.7 | -349.9% |
| Shares Outstanding (Mil) | 20 | 299 | -93.2% |
| Cumulative Contribution | -89.2% |
Market Drivers
12/31/2025 to 7/29/2026| Return | Correlation | |
|---|---|---|
| SRXH | -89.2% | |
| Market (SPY) | 7.3% | 3.0% |
| Sector (XLP) | 13.1% | -1.2% |
Fundamental Drivers
The -95.9% change in SRXH stock from 6/30/2025 to 7/29/2026 was primarily driven by a -95.2% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 6302025 | 7292026 | Change |
|---|---|---|---|
| Stock Price ($) | 35.16 | 1.45 | -95.9% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | � | -17 | 0.0% |
| P/S Multiple | � | -25.7 | 0.0% |
| Shares Outstanding (Mil) | 14 | 299 | -95.2% |
| Cumulative Contribution | 0.0% |
Market Drivers
6/30/2025 to 7/29/2026| Return | Correlation | |
|---|---|---|
| SRXH | -95.9% | |
| Market (SPY) | 19.1% | 1.9% |
| Sector (XLP) | 10.1% | 0.4% |
Fundamental Drivers
nullnull
Market Drivers
6/30/2023 to 7/29/2026| Return | Correlation | |
|---|---|---|
| SRXH | -99.7% | |
| Market (SPY) | 70.4% | 7.9% |
| Sector (XLP) | 26.9% | -0.8% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| SRXH Return | -58% | -83% | -49% | -81% | -90% | -89% | -100% |
| Peers Return | -4% | -20% | 105% | 26% | -20% | -4% | 52% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 9% | 98% |
Monthly Win Rates [3] | |||||||
| SRXH Win Rate | 33% | 33% | 42% | 25% | 42% | 14% | |
| Peers Win Rate | 48% | 54% | 54% | 48% | 45% | 57% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 43% | |
Max Drawdowns [4] | |||||||
| SRXH Max Drawdown | -72% | -89% | -85% | -87% | -91% | -91% | |
| Peers Max Drawdown | -25% | -45% | -35% | -24% | -42% | -39% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: FRPT, GLXY, GIS, COIN, SJM.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 7/29/2026 (YTD)
How Low Can It Go
| Event | SRXH | S&P 500 |
|---|---|---|
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -52.8% | -9.5% |
| % Gain to Breakeven | 111.9% | 10.5% |
| Time to Breakeven | 14 days | 24 days |
| 2020 COVID-19 Crash | ||
| % Loss | -18.7% | -33.7% |
| % Gain to Breakeven | 23.1% | 50.9% |
| Time to Breakeven | 2 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -52.4% | -19.2% |
| % Gain to Breakeven | 110.0% | 23.8% |
| Time to Breakeven | 7 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -96.2% | -12.2% |
| % Gain to Breakeven | 2500.0% | 13.9% |
| Time to Breakeven | 74 days | 62 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -28.6% | -6.8% |
| % Gain to Breakeven | 40.0% | 7.3% |
| Time to Breakeven | 49 days | 15 days |
| 2013 Taper Tantrum | ||
| % Loss | -44.4% | -0.2% |
| % Gain to Breakeven | 80.0% | 0.2% |
| Time to Breakeven | 56 days | 1 days |
In The Past
SRX Global's stock fell -52.8% during the Summer-Fall 2023 Five Percent Yield Shock. Such a loss loss requires a 111.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | SRXH | S&P 500 |
|---|---|---|
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -52.8% | -9.5% |
| % Gain to Breakeven | 111.9% | 10.5% |
| Time to Breakeven | 14 days | 24 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -52.4% | -19.2% |
| % Gain to Breakeven | 110.0% | 23.8% |
| Time to Breakeven | 7 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -96.2% | -12.2% |
| % Gain to Breakeven | 2500.0% | 13.9% |
| Time to Breakeven | 74 days | 62 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -28.6% | -6.8% |
| % Gain to Breakeven | 40.0% | 7.3% |
| Time to Breakeven | 49 days | 15 days |
| 2013 Taper Tantrum | ||
| % Loss | -44.4% | -0.2% |
| % Gain to Breakeven | 80.0% | 0.2% |
| Time to Breakeven | 56 days | 1 days |
In The Past
SRX Global's stock fell -52.8% during the Summer-Fall 2023 Five Percent Yield Shock. Such a loss loss requires a 111.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About SRX Global (SRXH)
Better Choice Company Inc. (trading under the symbol SRXH) operates as an animal health and wellness company, primarily focused on the pet care market. The company develops and sells a wide variety of naturally formulated products designed to support the health and well-being of dogs and cats.
Its comprehensive product portfolio includes naturally formulated kibble and canned dog and cat foods, alongside specialized offerings such as freeze-dried raw dog foods and treats, and vegan dog foods and treats. Beyond nutrition, Better Choice Company provides oral care products, supplements, toppers, dental products, chews, and grooming essentials, all marketed under its well-recognized brand names, Halo and TruDog.
The company primarily targets pet parents as its customers, catering to both dogs and cats. Better Choice Company Inc. utilizes a robust multi-channel distribution strategy, making its products available through its own online portals, various online retailers, and dedicated pet specialty stores. Geographically, the company has established a significant international presence, with operations extending across the United States, Canada, China, and other regions in Asia.
AI Analysis | Feedback
Here are 1-3 brief analogies for SRX Global (SRXH):
- Like a Blue Buffalo for a broader range of natural pet food and wellness products.
- A Warby Parker or Dollar Shave Club for premium pet food and wellness, emphasizing online sales of its own brands.
AI Analysis | Feedback
- Naturally Formulated Pet Foods: Kibble and canned food options for dogs and cats, made with natural ingredients.
- Freeze-Dried Raw Pet Products: Raw food and treats for dogs, processed using a freeze-drying method.
- Vegan Pet Products: Plant-based food and treats designed for dogs.
- Pet Oral Care and Supplements: Products aimed at maintaining pets' dental health and providing dietary supplements.
- Pet Food Toppers: Additives used to enhance the flavor or nutritional value of pet food.
- Pet Dental Chews & Products: Items designed to promote dental hygiene through chewing or direct application.
- Pet Grooming Products: Products used for the cleaning and aesthetic care of pets.
AI Analysis | Feedback
The company, Better Choice Company Inc. (trading as SRXH), sells its products primarily to individual pet owners, often referred to as "pet parents." While it utilizes online retailers and pet specialty stores as distribution channels, the ultimate consumers of its animal health and wellness products are individuals caring for their pets.
Based on its product portfolio under the Halo and TruDog brand names, Better Choice Company Inc. serves the following three categories of customers:
- Dog Owners: Individuals who purchase a diverse range of products for their dogs, including naturally formulated kibble and canned foods, freeze-dried raw foods and treats, and vegan options. This category also includes customers seeking dog-specific oral care, supplements, and grooming products.
- Cat Owners: Individuals who purchase naturally formulated kibble and canned foods specifically designed for cats, primarily under the Halo brand, along with general pet wellness products applicable to felines.
- Health-Conscious Pet Parents: A cross-segment of both dog and cat owners who prioritize premium, natural, and specialized ingredients and solutions for their pets' overall well-being. These customers are likely interested in products that address specific dietary needs, provide nutritional supplements, or support dental and grooming routines.
AI Analysis | Feedback
null
AI Analysis | Feedback
SRX Global (symbol: SRXH) is now known as SRx Health Solutions Inc., having completed a business combination with Better Choice Company Inc. in April 2025. Better Choice Company Inc. changed its legal name to SRx Health Solutions Inc. and its stock ticker from "BTTR" to "SRXH". The company focuses on health and wellness products and services for pets, people, and families.
The management team of SRx Health Solutions Inc. (SRXH) includes:
Kent Cunningham – Chief Executive Officer
Mr. Cunningham serves as the CEO of SRX Global Inc. and was previously the CEO of Better Choice Company prior to the SRx acquisition. He possesses 25 years of experience in leading, scaling, and turning around brands in the Health and Wellness, Pet Food, and Vitamins and Mineral Supplements categories. He has experience operating within multi-billion global enterprises and navigating entrepreneurial, private equity-backed businesses. Prior to his current role, Mr. Cunningham was CEO of 1440 Foods, a private equity-backed sports and active nutrition company. He was also General Manager at The Bountiful Company, a KKR private equity asset that was sold to Nestle Health for $5.75 billion USD.
Nina Martinez – Chief Financial Officer
Ms. Martinez (also known as Carolina) serves as the Chief Financial Officer of SRX Global Inc. She was appointed as CFO of Better Choice Company in August 2023, after serving as Interim CFO. Before joining Better Choice, she was Interim CFO for a consumer packaged goods company at ONE10 Advisors, where she led the company through IPO readiness. Ms. Martinez also spent eight years in Assurance leadership roles in the retail and consumer sector at PricewaterhouseCoopers.
Eric Jackson, Ph.D. – President, EMJX Platform and Head of Asset Management
Dr. Jackson serves as President, EMJX Platform and Head of Asset Management of SRx Global. He founded EMJ Capital Ltd in 2017, where he is the Founder/President and Portfolio Manager. He was an investor in Yahoo and Viacom as a Managing Director at SpringOwl Event Driven Partners from 2014 to 2016. Dr. Jackson co-founded and was the Portfolio Manager of Ironfire Capital LLC from 2008 to 2014. His background also includes serving as President of Jackson Leadership Systems from 2004 to 2008 and Vice President of Business Development at VoiceGenie Technologies Inc from 2000 to 2004.
AI Analysis | Feedback
For SRX Global Inc. (symbol: SRXH), the key risks to the business are primarily centered around its financial stability, the unproven nature of its new AI-driven investment strategy, and significant shareholder dilution.
- Financial Instability and Limited Cash Runway: SRX Global Inc. faces substantial financial challenges, evidenced by having less than a year of cash runway based on its current free cash flow trend, with reported negative free cash flow of approximately US$17 million to US$26 million. The company's earnings have also declined by 39% per year over the past five years. This precarious financial position necessitates raising additional capital or achieving a significant improvement in cash flows, which could lead to further financial strain.
- Risks Associated with New AI-Driven Investment and Digital Asset Strategy: The company recently underwent a significant strategic shift, acquiring EMJ Crypto Technologies and rebranding to focus on an AI-driven platform for allocating capital across high-conviction operating companies, strategic assets, and technology-enabled opportunities, including digital assets. The effectiveness of this proprietary AI platform in consistently generating strategic returns is yet to be proven. Furthermore, the company's "EMJX stress model" for its digital asset treasury has recently shifted to "STRESS" from "MIXED," indicating heightened market risks for its digital asset investments. This new, diversified, and highly speculative investment approach introduces considerable risk and uncertainty.
- Significant Shareholder Dilution and High Stock Volatility: Shareholders of SRXH have experienced substantial dilution, with shares outstanding increasing by over 24 times in the past year. The company's stock price has also been highly volatile, with average weekly changes ranging from 17% to 28% over the past three months, making it more volatile than a significant majority of American stocks. This extreme volatility and dilution can erode investor confidence and make it challenging to attract and retain capital.
AI Analysis | Feedback
null
AI Analysis | Feedback
SRX Global (symbol: SRXH), operating as Better Choice Company Inc., is involved in the animal health and wellness industry, offering naturally formulated pet foods, freeze-dried raw foods and treats, vegan products, oral care products, and supplements under the Halo and TruDog brands. The addressable markets for its main products and services are substantial both globally and within the U.S.
Pet Food Market
- The global pet food market was valued at approximately USD 128.7 billion in 2025 and is projected to grow to USD 191.2 billion by 2033. Another estimate places the global market at USD 132.4 billion in 2025, expected to reach USD 247.7 billion by 2035.
- In the U.S., the pet food market reached approximately USD 46.90 billion in 2025 and is projected to exceed USD 62.10 billion by 2034. Other reports indicate the U.S. pet food market size was around USD 43.45 billion in 2024.
Pet Treats Market
- Globally, the pet treats market was estimated at USD 40.52 billion in 2024 and is projected to reach USD 79.23 billion by 2030. Another source reported a global market size of USD 43.86 billion in 2025, predicted to reach USD 150.02 billion by 2035.
- The U.S. pet snacks and treats market was estimated at USD 17.57 billion in 2024 and is projected to reach USD 34.48 billion by 2030. In 2025, the U.S. market for pet treats was valued at USD 10.50 billion, with a projected growth to USD 15.84 billion by 2031.
Pet Supplements Market
- The global pet supplements market size was valued at USD 3.14 billion in 2025 and is projected to grow to USD 5.47 billion by 2034. Another estimate places the global market at USD 2.81 billion in 2025, predicted to increase to USD 6.61 billion by 2035.
- The U.S. pet supplements market was estimated at USD 779.78 million in 2025 and is expected to reach nearly USD 1,871.46 million in 2035. Other data suggests the U.S. pet supplement market sales exceeded USD 2.7 billion.
Pet Oral Care Products Market
- The global pet oral care products market size was valued at USD 3.49 billion in 2025 and is projected to grow to USD 6.25 billion by 2034. In 2026, the market is likely to be valued at USD 2.2 billion, projected to reach USD 3.5 billion by 2033.
- The U.S. pet dental health market size was approximately USD 3.15 billion in 2024 and is projected to reach around USD 5.95 billion by 2034. Another report estimated the U.S. pet dental health market size at USD 2.59 billion in 2024, projected to reach USD 4.53 billion by 2033.
AI Analysis | Feedback
Here are 3-5 expected drivers of future revenue growth for SRX Global (symbol: SRXH) over the next 2-3 years:
- AI-Driven Capital Allocation and Strategic Investments: SRX Global's core strategy involves leveraging its proprietary AI platform to enhance decision-making in capital allocation towards high-conviction operating companies and assets. The company aims to generate and multiply strategic returns by building, operating, and scaling exceptional businesses through this AI-powered approach, with an explicit focus on opportunistic investments.
- Growth and Scaling of Acquired and Portfolio Businesses: The company plans to drive growth by integrating and scaling businesses acquired or developed under its new platform. This includes entities like EMJX Crypto Technologies, Inc., which was recently acquired, and other investments in companies such as Astro Capital, Opendoor Technologies Inc., Uber Technologies, and Optimi Health Corp.
- Continued Expansion of the Halo Pet Health and Wellness Brand: Despite the company's broader strategic shift, the Halo brand remains a component of the SRX Global platform. Management has indicated a continued focus on "growing our Halo® business," which has previously demonstrated positive momentum, including a 26% increase in Q4 revenue year-over-year and 18% international growth for the brand in 2024.
- Strategic Mergers and Acquisitions (M&A): SRX Global has a history of strategic acquisitions, notably the merger with SRx Health Solutions Inc. and the recent acquisition of EMJX Crypto Technologies, Inc.. These transactions are expected to contribute to significant revenue and operational efficiencies, with the combined entities of Better Choice and SRx Health projecting over USD$270 million in revenue for 2025. The company continues to pursue strategic actions centered on capital allocation towards high-growth assets.
AI Analysis | Feedback
Share Repurchases
- Better Choice Company reinstated and expanded its stock repurchase program, authorizing up to $6.5 million in repurchases through December 31, 2025.
- Under a previous $5 million program that expired on December 31, 2024, the company repurchased 102,405 common shares at an average price of $1.9869 per share.
Share Issuance
- In connection with the merger with SRx Health Solutions, Better Choice Company issued 28.6 million shares of common stock in April 2025.
- The company completed an $8.8 million private placement in April 2025, selling 4,036,697 shares of common stock and pre-funded warrants at $2.18 per share.
- Better Choice Company Inc. closed a public offering in July 2024, raising approximately $5 million in gross proceeds through the issuance of common stock and pre-funded warrants.
- On November 19, 2025, the company significantly increased its authorized common stock from 200,000,000 shares to 5,000,000,000 shares.
- A spin-out distribution was announced in April 2025, where stockholders of record received one share of Class A Common Stock of Halo Spin-Out SPV Inc. for every one share of company stock held.
Inbound Investments
- An $8.8 million private placement with an institutional investor was completed in April 2025, coinciding with the merger with SRx Health Solutions.
- The company received $6.5 million in cash upfront as part of the sale of Halo's business in Asia.
Outbound Investments
- Better Choice Company acquired SRx Health Solutions, Inc. in an all-stock transaction that closed on April 24, 2025.
Capital Expenditures
- Cash used in investing activities for the nine months ended September 30, 2024, was $1.5 million, with capital expenditures accounting for less than $0.1 million.
- For the nine months ended September 30, 2023, capital expenditures were less than $0.1 million.
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 49.93 |
| Mkt Cap | 8.5 |
| Rev LTM | 7,805 |
| Op Inc LTM | 818 |
| FCF LTM | 1,156 |
| FCF 3Y Avg | 872 |
| CFO LTM | 1,474 |
| CFO 3Y Avg | 1,304 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 3.7% |
| Rev Chg 3Y Avg | 12.0% |
| Rev Chg Q | -15.5% |
| QoQ Delta Rev Chg LTM | -3.5% |
| Op Inc Chg LTM | -18.8% |
| Op Inc Chg 3Y Avg | 111.3% |
| Op Mgn LTM | 11.1% |
| Op Mgn 3Y Avg | 17.0% |
| QoQ Delta Op Mgn LTM | 0.5% |
| CFO/Rev LTM | 16.3% |
| CFO/Rev 3Y Avg | 14.7% |
| FCF/Rev LTM | 9.0% |
| FCF/Rev 3Y Avg | 10.0% |
Price Behavior
Price Behavior
| Market Price | $1.45 | |
| Market Cap ($ Bil) | 0.4 | |
| First Trading Date | 06/16/2010 | |
| Distance from 52W High | -95.8% | |
| 50 Days | 200 Days | |
| DMA Price | $5.49 | $11.31 |
| DMA Trend | down | down |
| Distance from DMA | -73.6% | -87.2% |
| 3M | 1YR | |
| Volatility | 248.5% | 193.9% |
| Downside Capture | 183.11 | 138.32 |
| Upside Capture | -560.16 | -228.43 |
| Correlation (SPY) | -0.6% | 1.7% |
SRXH Betas & Captures as of 6/30/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.11 | 1.63 | 1.23 | 0.98 | 0.67 | -4.95 |
| Up Beta | -3.00 | -3.58 | -2.38 | -1.12 | -0.12 | -33.20 |
| Down Beta | 2.67 | 2.46 | 1.78 | 1.23 | 2.13 | 0.16 |
| Up Capture | 20% | 150% | 163% | 38% | -34% | 63% |
| Bmk +ve Days | 11 | 24 | 40 | 67 | 140 | 429 |
| Stock +ve Days | 9 | 15 | 26 | 48 | 109 | 125 |
| Down Capture | 211% | 317% | 370% | 213% | 148% | 81% |
| Bmk -ve Days | 10 | 17 | 23 | 58 | 112 | 321 |
| Stock -ve Days | 7 | 21 | 31 | 71 | 137 | 161 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with SRXH | |
|---|---|---|---|---|
| SRXH | -84.0% | 182.2% | -0.21 | - |
| Sector ETF (XLP) | 10.6% | 14.1% | 0.48 | -4.5% |
| Equity (SPY) | 15.6% | 12.8% | 0.86 | 4.4% |
| Gold (GLD) | 21.6% | 28.1% | 0.68 | 1.8% |
| Commodities (DBC) | 31.5% | 19.7% | 1.27 | -2.1% |
| Real Estate (VNQ) | 15.9% | 14.0% | 0.82 | 0.3% |
| Bitcoin (BTCUSD) | -46.1% | 42.9% | -1.32 | 7.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with SRXH | |
|---|---|---|---|---|
| SRXH | -78.9% | 139.5% | -0.48 | - |
| Sector ETF (XLP) | 7.0% | 13.6% | 0.29 | 1.6% |
| Equity (SPY) | 12.4% | 17.1% | 0.55 | 10.1% |
| Gold (GLD) | 17.1% | 18.4% | 0.75 | 2.3% |
| Commodities (DBC) | 9.3% | 19.5% | 0.36 | 2.6% |
| Real Estate (VNQ) | 2.9% | 18.9% | 0.05 | 4.9% |
| Bitcoin (BTCUSD) | 14.7% | 53.3% | 0.46 | 4.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with SRXH | |
|---|---|---|---|---|
| SRXH | -62.4% | 175.5% | 0.12 | - |
| Sector ETF (XLP) | 7.4% | 14.8% | 0.37 | 4.3% |
| Equity (SPY) | 14.7% | 17.9% | 0.70 | 8.3% |
| Gold (GLD) | 11.3% | 16.1% | 0.57 | -1.7% |
| Commodities (DBC) | 7.1% | 18.0% | 0.32 | 0.5% |
| Real Estate (VNQ) | 5.1% | 20.7% | 0.21 | 5.6% |
| Bitcoin (BTCUSD) | 57.7% | 66.2% | 0.98 | 2.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Updated 7/28/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 3/31/2025 | -1.2% | -3.5% | 12.8% |
| 11/15/2024 | 0.0% | 2.9% | 17.6% |
| 8/26/2024 | -1.5% | -19.1% | -37.3% |
| 5/21/2024 | -5.2% | 17.0% | 25.2% |
| 11/14/2023 | -4.7% | 29.6% | 37.7% |
| 8/22/2023 | 4.2% | 2.3% | -31.6% |
| 5/12/2023 | 0.0% | -4.8% | -40.5% |
| 11/10/2022 | -4.6% | -16.6% | -41.0% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 8 | 7 | 7 |
| # Negative | 7 | 8 | 8 |
| Median Positive | 3.3% | 5.0% | 24.6% |
| Median Negative | -4.6% | -8.2% | -34.4% |
| Max Positive | 14.4% | 29.6% | 37.7% |
| Max Negative | -7.6% | -19.1% | -42.4% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 3/31/2025 | -1.2% | -3.5% | 12.8% |
| 11/15/2024 | 0.0% | 2.9% | 17.6% |
| 8/26/2024 | -1.5% | -19.1% | -37.3% |
| 5/21/2024 | -5.2% | 17.0% | 25.2% |
| 11/14/2023 | -4.7% | 29.6% | 37.7% |
| 8/22/2023 | 4.2% | 2.3% | -31.6% |
| 5/12/2023 | 0.0% | -4.8% | -40.5% |
| 11/10/2022 | -4.6% | -16.6% | -41.0% |
| 8/11/2022 | 6.1% | -11.7% | -42.4% |
| 5/12/2022 | 14.4% | 5.0% | 35.8% |
| 11/10/2021 | 1.0% | -0.3% | -15.9% |
| 8/12/2021 | -7.6% | -15.7% | -3.2% |
| 5/13/2021 | 2.5% | 0.8% | 24.6% |
| 11/18/2020 | -1.1% | 18.2% | 4.5% |
| 8/18/2020 | 12.5% | -3.1% | -21.9% |
| SUMMARY STATS | |||
| # Positive | 8 | 7 | 7 |
| # Negative | 7 | 8 | 8 |
| Median Positive | 3.3% | 5.0% | 24.6% |
| Median Negative | -4.6% | -8.2% | -34.4% |
| Max Positive | 14.4% | 29.6% | 37.7% |
| Max Negative | -7.6% | -19.1% | -42.4% |
Industry Resources
| Consumer Staples Resources |
| FoodNavigator |
| Consumer Goods Technology (CGT) |
| Beverage Digest |
| Packaged Foods & Meats Resources |
| USDA Data |
| Food Processing |
| Meat+Poultry |
| Just Food |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.
Core Cache Last Updated: 7/29/2026